Medical

$38M funding boost for diabetes and cardiovascular disease research – MTPConnect

Health Industry Hub | January 13, 2021 |
[Total: 1    Average: 5/5]

Medical News: MTPConnect and the Minister for Health & Aged Care, the Hon. Greg Hunt MP call for Expressions of Interest (EOI) for two new Research Centres and the first round of Research Projects funding.

The Targeted Translation Research Accelerator (TTRA), a Medical Research Future Fund initiative delivered by MTPConnect, is rolling out a new funding opportunity to improve the prevention, diagnosis, management and treatment of diabetes, cardiovascular disease and their related complications.

MTPConnect Managing Director and CEO, Dr Dan Grant, said the funding opportunities signal a new approach to boosting the translation and commercialisation of Australian research into diabetes and cardiovascular disease, leading causes of death and disability in Australia.

“This is a substantial and targeted injection of funding which will support whole-of-sector coordination to maximise the development and translation of specific, highly promising research projects,” Dr Grant said.

“To stimulate collaboration across industry, research and clinical organisations we’re allocating $20 million to support the establishment of two new Research Centres; one focused on diabetes-associated complications and the other on cardiovascular disease-associated
complications and each funded for up to $10 million over four years.

“In a parallel program, we’re making available $18 million to support translational Research Projects that have the potential to transform diabetes and cardiovascular disease outcomes and reduce the burden of disease on patients, families and the community – with up to $6 million available in this first round.

“We’ll support eligible organisations seeking $200,000-$750,000 for up to 24 months who provide an in-kind contribution to the value of 50% of the funding requested to develop innovative preventative, diagnostic, therapeutic and disease management products and solutions for identified priorities associated with diabetes and cardiovascular disease.

“A number of priorities for both programs have been identified following deep consultation with the sector and focus on the complications associated with both diseases and unmet needs.

“A distinguishing feature of the TTRA is the emphasis on translation with our TTRA program partners – ANDHealth, Medical Device Partnering Program and UniQuest – providing mentoring and commercialisation advice to applicants and those receiving funding,” Dr Grant said.

TTRA Expert Advisory Board Chair, Professor Ian Frazer AC FRS, explained why these new research funding opportunities are essential in improving outcomes for those living with diabetes and cardiovascular disease.

“Diabetes, cardiovascular disease and their related complications are significant chronic health conditions, not only in Australia, but globally with substantial unmet need,” he said.

“Through investment in projects as well as the establishment of two unique Research Centres in Australia, MTPConnect’s TTRA Program will support and accelerate the translation of innovative preventative, diagnostic and therapeutic approaches and products towards clinical impact and to those who need it most,” Professor Frazer said.

Submissions for the first round of Research Projects closes at 16:00 AEDT Monday 22 February 2021.

Information Sessions via webinar are scheduled for mid-January.

  • TTRA Research Projects Information Session: 19 January 2021 – Register here.
  • TTRA Research Centres Information Session: 20 January 2021 – Register here.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Sustained COVID-19 impact on cancer services and procedures

Sustained COVID-19 impact on cancer services and procedures

Health Industry Hub | January 15, 2021 |

MedTech News: Cancer Australia has released the latest in a series of reports analysing for the first time the significance […]

More


News & Trends - Medical Technology

MedTech News - Healthscope hospital leading in high-tech medical surgery

Healthscope hospital leading in high-tech medical surgery

Health Industry Hub | January 15, 2021 |

MedTech News: Healthscope’s Knox Private Hospital recently celebrated two key milestones, underscoring its reputation as a leading proponent of high-tech […]

More


News & Trends - Pharmaceuticals

Pharma News - Experts comment on AstraZeneca vaccine efficacy concerns

Experts comment on AstraZeneca vaccine efficacy concerns

Health Industry Hub | January 15, 2021 |

Pharma News: In light of the comments made regarding AstraZeneca’s COVID-19 vaccine efficacy by the Australian and New Zealand Society […]

More


Communication

Communication Pharma Biotech Medtech - Secrets of persuasion to influence anyone

Secrets of persuasion to influence anyone

Health Industry Hub | January 15, 2021 |

To understand the art of persuasion, you can turn to cognitive science for guidance in dealing with the unconscious mind. […]

More